Heng Fai Ambrose Chan, Director: Impact Biomedical IBO Sell · Filed 25/04/04

Trade details

Type: Insider sale
Amount: $221,807.66
Shares · price: 382,427 sh · $0.58 a share
Held after: 351,631 sh
Stock: Impact Biomedical IBO
Person: Heng Fai Ambrose ChanDirector
Trade date: 25/04/02
Filed: 25/04/04
Days to filing: 2 days

Sold 52.1% of holdings

Share of holding sold: 52.1%

Impact Biomedical trades, last 26 weeks

What else happened in Impact Biomedical around then

Filed or reported within 30 days of the trade day · 25/03/03~25/05/02

Heng Fai Ambrose Chan's recent trades

Heng Fai Ambrose ChanChairman and Chief Executive Officer
Planned saleAlset
Planned sale
Alset
AEI
$604.2K
380,000 sh
$604.2K
Filed 08/25
Traded 08/26
Heng Fai Ambrose ChanCEO
BuyHWH International
Buy
HWH International
HWH
$500K
250,000 sh
$500K
Filed 06/09
Traded 06/08
Heng Fai Ambrose ChanCEO
SellHWH International
Sell
HWH International
HWH
$98.4K
100,390 sh
$98.4K
Filed 04/01
Traded 03/30
Heng Fai Ambrose ChanCEO
Planned saleHWH International
Planned sale
HWH International
HWH
$459.7K
300,465 sh
$459.7K
Filed 02/11
Traded 02/12
Heng Fai Ambrose ChanCEO
SellAlset
Sell
Alset
AEI
$1.3M
500,000 sh
$1.3M
Filed 25/09/16
Traded 25/09/12

Heng Fai Ambrose Chan, Director — sold $221.8K of Impact Biomedical IBO · 52.1% of holdings | Whalegun